Pfizer Establishes Durham, North Carolina, Clinical Manufacturing Campus
12/23/2021
According to company officials, the facility will be responsible for the manufacturing and analytical release of clinical supplies for Pfizer’s gene therapy and biologics portfolio. Approximately 40 employees will relocate from the company’s Chapel Hill site.
The Durham facility is part of an $800 million investment over the past six years to build three scalable, state-of-the-art gene therapy manufacturing facilities to support Pfizer’s continued investment in gene therapy research, development, and manufacturing.
“Gene therapy represents the next wave of innovation for patients living with rare diseases, for whom there are limited treatment options currently available,” said Paul Mensah, Vice President, BioTherapeutics Pharmaceutical Sciences at Pfizer. “Today represents the next step in strengthening Pfizer’s in-house gene therapy capabilities and underscores the unique ability, expertise, and resources we have to guide gene therapy through the entire development and manufacturing process and deliver this potentially life-changing technology to patients.”
Pfizer currently employs more than 3,600 people across its North Carolina sites, according to company officials. The new Durham location is an important part of Pfizer’s worldwide R&D network which includes locations in La Jolla, California; Boulder, Colorado; St Louis, Missouri; Pearl River, New York; Groton, Connecticut; and Cambridge and Andover, Massachusetts.
Project Announcements
GE Vernova Expands Schenectady, New York, Operations
05/26/2023
Southern Rock Energy Partners Plans Cushing, Oklahoma, Crude Oil Refinery
05/26/2023
ForwardEdge ASIC Establishes St. Paul, Minnesota, Operations
05/26/2023
Spain-Based Cosentino Group Plans Jacksonville, Florida, Manufacturing Plant
05/26/2023
Michelin Expands Junction City, Kansas, Operations
05/26/2023
Italy-Based Alpitronic Americas Plans Charlotte, North Carolina, U.S. Headquarters-Operations
05/25/2023
Most Read
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
19th Annual Consultants Survey: Clients Challenged by Tight Labor Market, Energy Availability
Q1 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Manufacturing and Distribution Trends Impact the Value of Credits and Incentives
Q1 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023